...
tnfa-img

TNF Pharmaceuticals, Inc., Common Stock

TNFA

NAQ

$1.29

+$0.02

(1.57%)

1D
Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$3.13M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
78.34K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
2.67
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.05 L
$10.68 H
$1.29

About TNF Pharmaceuticals, Inc., Common Stock

TNF Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on developing two novel therapeutic platforms that treat the causes of disease rather than addressing the symptoms. Its MYMD-1 is a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines. The MYMD-1 is being developed to treat diseases and disorders marked by acute or chronic inflammation. The company's second drug platform, Supera-CBD, is being developed to treat chronic pain, addiction, and epilepsy. The Supera-CBD is a novel synthetic derivative of cannabidiol (CBD) and is being developed to address and improve the growing CBD market, which includes FDA approved drugs and CBD products not regulated as drugs. TNF Pharmaceuticals, Inc. was formerly known as MyMD Pharmaceuticals, Inc. and changed its name to TNF Pharmaceuticals, Inc. in July 2024. The company was founded in 2014 and is headquartered in Baltimore, Maryland. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time FrameTNFASectorS&P500
1-Week Return-12.24%2.44%2.58%
1-Month Return-4.44%-4.49%0.09%
3-Month Return-22.75%-8.82%4.76%
6-Month Return-31.75%-4.46%9.89%
1-Year Return-81.93%3.16%26.47%
3-Year Return-99.25%-0.83%25.98%
5-Year Return-99.33%35.65%86.34%
10-Year Return-100%101.94%189.21%

Financials

Dec '20Dec '21Dec '22Dec '23
Total Revenue----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue29.45K---[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Profit(29.45K)---[{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Margin----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Operating Expenses12.26M28.20M15.28M17.12M[{"date":"2020-12-31","value":43.46,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":54.19,"profit":true},{"date":"2023-12-31","value":60.72,"profit":true}]
Operating Income(12.29M)(28.20M)(15.28M)(17.12M)[{"date":"2020-12-31","value":-1228570000,"profit":false},{"date":"2021-12-31","value":-2820125000,"profit":false},{"date":"2022-12-31","value":-1528276000,"profit":false},{"date":"2023-12-31","value":-1712305200,"profit":false}]
Total Non-Operating Income/Expense(1.19M)(1.68M)169.42K13.58M[{"date":"2020-12-31","value":-8.78,"profit":false},{"date":"2021-12-31","value":-12.36,"profit":false},{"date":"2022-12-31","value":1.25,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(12.15M)(29.89M)(15.20M)(4.00M)[{"date":"2020-12-31","value":-1215221400,"profit":false},{"date":"2021-12-31","value":-2988904500,"profit":false},{"date":"2022-12-31","value":-1519733600,"profit":false},{"date":"2023-12-31","value":-399995000,"profit":false}]
Income Taxes5.43M(18.33K)(15.28M)(16.36M)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-0.34,"profit":false},{"date":"2022-12-31","value":-281.53,"profit":false},{"date":"2023-12-31","value":-301.38,"profit":false}]
Income After Taxes(17.58M)(29.87M)85.43K12.36M[{"date":"2020-12-31","value":-142.23,"profit":false},{"date":"2021-12-31","value":-241.67,"profit":false},{"date":"2022-12-31","value":0.69,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Income From Continuous Operations(9.49M)(29.89M)(15.20M)(4.00M)[{"date":"2020-12-31","value":-948782400,"profit":false},{"date":"2021-12-31","value":-2988904500,"profit":false},{"date":"2022-12-31","value":-1519733600,"profit":false},{"date":"2023-12-31","value":-399995000,"profit":false}]
Income From Discontinued Operations----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(17.58M)(29.89M)(15.20M)(4.00M)[{"date":"2020-12-31","value":-1758060900,"profit":false},{"date":"2021-12-31","value":-2988904500,"profit":false},{"date":"2022-12-31","value":-1519733600,"profit":false},{"date":"2023-12-31","value":-399995000,"profit":false}]
EPS (Diluted)(299.36)(32.47)(11.77)(5.65)[{"date":"2020-12-31","value":-29936.13,"profit":false},{"date":"2021-12-31","value":-3246.57,"profit":false},{"date":"2022-12-31","value":-1177.47,"profit":false},{"date":"2023-12-31","value":-564.54,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

TNFA
Cash Ratio 1.52
Current Ratio 1.72

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

TNFA
ROA (LTM) -32.43%
ROE (LTM) -297.63%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

TNFA
Debt Ratio Lower is generally better. Negative is bad. 0.29
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.71

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

TNFA
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 0.44
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is TNF Pharmaceuticals, Inc. share price today?

TNF Pharmaceuticals, Inc. (TNFA) share price today is $1.29

Can Indians buy TNF Pharmaceuticals, Inc. shares?

Yes, Indians can buy shares of TNF Pharmaceuticals, Inc. (TNFA) on Vested. To buy TNF Pharmaceuticals, Inc. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in TNFA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of TNF Pharmaceuticals, Inc. be purchased?

Yes, you can purchase fractional shares of TNF Pharmaceuticals, Inc. (TNFA) via the Vested app. You can start investing in TNF Pharmaceuticals, Inc. (TNFA) with a minimum investment of $1.

How to invest in TNF Pharmaceuticals, Inc. shares from India?

You can invest in shares of TNF Pharmaceuticals, Inc. (TNFA) via Vested in three simple steps:

  • Click on Sign Up or Invest in TNFA stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in TNF Pharmaceuticals, Inc. shares
What is TNF Pharmaceuticals, Inc. 52-week high and low stock price?

The 52-week high price of TNF Pharmaceuticals, Inc. (TNFA) is $10.68. The 52-week low price of TNF Pharmaceuticals, Inc. (TNFA) is $1.05.

What is TNF Pharmaceuticals, Inc. price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of TNF Pharmaceuticals, Inc. (TNFA) is

What is TNF Pharmaceuticals, Inc. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of TNF Pharmaceuticals, Inc. (TNFA) is 0.44

What is TNF Pharmaceuticals, Inc. dividend yield?

The dividend yield of TNF Pharmaceuticals, Inc. (TNFA) is 0.00%

What is the Market Cap of TNF Pharmaceuticals, Inc.?

The market capitalization of TNF Pharmaceuticals, Inc. (TNFA) is $3.13M

What is TNF Pharmaceuticals, Inc.’s stock symbol?

The stock symbol (or ticker) of TNF Pharmaceuticals, Inc. is TNFA

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top